Client News

Destiny Pharma strengthens Executive Management Team with the appointment of Dr Yuri Martina as Chief Medical Officer

Abivax publishes Universal Registration Document 2022 “Document d’Enregistrement Universel”

Marinomed’s Australian Carragelose distribution network strengthened

Deutsches Herzzentrum München veröffentlicht erste Ergebnisse aus „Vroni-Studie“: Bayerische Pilotstudie identifiziert 76 Kinder mit bedrohlicher Cholesterinstörung

Temedica wins further renowned industry representatives for expert advisory board

ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases

Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis

Marinomed reports on strong 2021 financial year

Secarna Pharmaceuticals’ strategic partner Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb

Destiny Pharma plc: Audited results for the year ended 31 December 2021